Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Reevaluating Zone Diameter Cutoffs.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
12 2019
Historique:
received: 11 07 2019
accepted: 03 10 2019
pubmed: 11 10 2019
medline: 17 7 2020
entrez: 11 10 2019
Statut: epublish

Résumé

The optimal method to screen for gastrointestinal colonization with carbapenem-resistant organisms (CRO) has yet to be established. The direct MacConkey (direct MAC) plate method demonstrates high sensitivity for CRO detection, but established zone diameter (ZD) criteria for ertapenem (≤27 mm) and meropenem (≤32 mm) result in high rates of false positives upon confirmatory testing. To increase specificity, we screened for CRO in two high-risk wards using the direct MAC plate method, recorded ZDs for each sample, and generated receiver operating characteristic (ROC) curves to evaluate the optimal ZD cutoff criteria. Of 6,868 swabs obtained over an 18-month period, 4,766 (69%) had growth on MAC plates, and 2,500 (36%) met criteria for further evaluation based on previously established ZDs around the carbapenem disks. A total of 812 (12%) swabs were confirmed positive for at least one CRO and included 213 (3%) carbapenemase-producing organisms (CPO), resulting in a specificity of 78% for the direct MAC plate method. Reducing the ertapenem and meropenem ZDs to ≤25 mm improved specificity to 83%, decreasing the confirmatory testing workload by 32%. The sensitivities with the lower ZD criteria were 89% for CRO and 94% for CPO, respectively. The direct MAC plate method criteria for CRO testing can be modified to balance the sensitivity and specificity of CRO while reducing the burden on clinical microbiology laboratories. These modifications can be particularly helpful in regions with a low CRO prevalence.

Identifiants

pubmed: 31597748
pii: JCM.01127-19
doi: 10.1128/JCM.01127-19
pmc: PMC6879279
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0
Meropenem FV9J3JU8B1
Ertapenem G32F6EID2H

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI130608
Pays : United States
Organisme : ACL HHS
ID : U54CK000447
Pays : United States
Organisme : NCEZID CDC HHS
ID : U54 CK000447
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Clin Microbiol. 2008 Sep;46(9):3110-1
pubmed: 18632915
J Clin Microbiol. 2010 Mar;48(3):836-41
pubmed: 20071553
J Clin Microbiol. 2017 Jul;55(7):2268-2275
pubmed: 28515213
Diagn Microbiol Infect Dis. 2014 Apr;78(4):356-9
pubmed: 24439449
J Clin Microbiol. 2013 Jan;51(1):331-3
pubmed: 23135936
Clin Microbiol Rev. 2016 Jan;29(1):1-27
pubmed: 26511484
J Clin Microbiol. 2011 Jun;49(6):2239-42
pubmed: 21471338
J Clin Microbiol. 2015 Dec;53(12):3729-37
pubmed: 26338860
J Clin Microbiol. 2016 Jun;54(6):1664-1667
pubmed: 27053674
Infect Control Hosp Epidemiol. 2017 Sep;38(9):1117-1119
pubmed: 28693656
J Clin Microbiol. 2017 Aug;55(8):2321-2333
pubmed: 28381609
Clin Infect Dis. 2017 Feb 1;64(3):257-264
pubmed: 28013264
Mayo Clin Proc. 2006 Apr;81(4):529-36
pubmed: 16610573
J Clin Microbiol. 2015 Jan;53(1):105-12
pubmed: 25355764
Clin Infect Dis. 2018 Nov 1;:
pubmed: 30383203
J Clin Microbiol. 2017 Dec 26;56(1):
pubmed: 29118172
Sci Transl Med. 2012 Aug 22;4(148):148ra116
pubmed: 22914622
Infect Control Hosp Epidemiol. 2016 May;37(5):544-8
pubmed: 26832307
J Clin Microbiol. 2016 Jul;54(7):1700-1710
pubmed: 26912753

Auteurs

Meklit Workneh (M)

Division of Medical Microbiology, Johns Hopkins School of Medicine, Harvard University, Cambridge, Massachusetts, USA.

Ruibin Wang (R)

Harvard University, School of Public Health, Cambridge, Massachusetts, USA.

Abida Q Kazmi (AQ)

Division of Medical Microbiology, Johns Hopkins School of Medicine, Harvard University, Cambridge, Massachusetts, USA.

Krizia K Chambers (KK)

Division of Medical Microbiology, Johns Hopkins School of Medicine, Harvard University, Cambridge, Massachusetts, USA.

Belita N A Opene (BNA)

Division of Medical Microbiology, Johns Hopkins School of Medicine, Harvard University, Cambridge, Massachusetts, USA.

Shawna Lewis (S)

Division of Medical Microbiology, Johns Hopkins School of Medicine, Harvard University, Cambridge, Massachusetts, USA.

Katherine Goodman (K)

University of Maryland School of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Pranita D Tamma (PD)

Division of Pediatric Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Karen C Carroll (KC)

Division of Medical Microbiology, Johns Hopkins School of Medicine, Harvard University, Cambridge, Massachusetts, USA.

Aaron M Milstone (AM)

Division of Pediatric Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Patricia J Simner (PJ)

Division of Medical Microbiology, Johns Hopkins School of Medicine, Harvard University, Cambridge, Massachusetts, USA psimner1@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH